These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The predictive power of synthetic nucleic acid technologies in RNA biology. Chakraborty S; Mehtab S; Krishnan Y Acc Chem Res; 2014 Jun; 47(6):1710-9. PubMed ID: 24712860 [TBL] [Abstract][Full Text] [Related]
44. An extra dimension in nucleic acid sequence recognition. Fox KR; Brown T Q Rev Biophys; 2005 Nov; 38(4):311-20. PubMed ID: 16737560 [TBL] [Abstract][Full Text] [Related]
45. Design and Hybridization Properties of Acyclic Xeno Nucleic Acid Oligomers. Murayama K; Asanuma H Chembiochem; 2021 Aug; 22(15):2507-2515. PubMed ID: 33998765 [TBL] [Abstract][Full Text] [Related]
46. Rethinking nucleic acids from their origins to their applications. Benner SA Philos Trans R Soc Lond B Biol Sci; 2023 Feb; 378(1871):20220027. PubMed ID: 36633284 [TBL] [Abstract][Full Text] [Related]
47. Molecular evolution of functional nucleic acids with chemical modifications. Kuwahara M; Sugimoto N Molecules; 2010 Aug; 15(8):5423-44. PubMed ID: 20714306 [TBL] [Abstract][Full Text] [Related]
48. Discovery and evolution of RNA and XNA reverse transcriptase function and fidelity. Houlihan G; Arangundy-Franklin S; Porebski BT; Subramanian N; Taylor AI; Holliger P Nat Chem; 2020 Aug; 12(8):683-690. PubMed ID: 32690899 [TBL] [Abstract][Full Text] [Related]
49. Designer nucleic acids to probe and program the cell. Krishnan Y; Bathe M Trends Cell Biol; 2012 Dec; 22(12):624-33. PubMed ID: 23140833 [TBL] [Abstract][Full Text] [Related]
50. Chemical Development of Therapeutic Oligonucleotides. Lundin KE; Gissberg O; Smith CIE; Zain R Methods Mol Biol; 2019; 2036():3-16. PubMed ID: 31410788 [TBL] [Abstract][Full Text] [Related]
51. Compartmentalized Self-Tagging for In Vitro-Directed Evolution of XNA Polymerases. Pinheiro VB; Arangundy-Franklin S; Holliger P Curr Protoc Nucleic Acid Chem; 2014 Jun; 57():9.9.1-18. PubMed ID: 24961724 [TBL] [Abstract][Full Text] [Related]
52. Novel drug discovery and molecular biological methods, via DNA, RNA and protein changes using structure-function transitions: Transitional structural chemogenomics, transitional structural chemoproteomics and novel multi-stranded nucleic acid microarray. Gagna CE; Lambert WC Med Hypotheses; 2006; 67(5):1099-114. PubMed ID: 16828979 [TBL] [Abstract][Full Text] [Related]
53. Xylonucleic acid: synthesis, structure, and orthogonal pairing properties. Maiti M; Maiti M; Knies C; Dumbre S; Lescrinier E; Rosemeyer H; Ceulemans A; Herdewijn P Nucleic Acids Res; 2015 Sep; 43(15):7189-200. PubMed ID: 26175047 [TBL] [Abstract][Full Text] [Related]
54. Insights from crystallographic studies into the structural and pairing properties of nucleic acid analogs and chemically modified DNA and RNA oligonucleotides. Egli M; Pallan PS Annu Rev Biophys Biomol Struct; 2007; 36():281-305. PubMed ID: 17288535 [TBL] [Abstract][Full Text] [Related]
55. Cycloadditions for Studying Nucleic Acids. Kath-Schorr S Top Curr Chem (Cham); 2016 Feb; 374(1):4. PubMed ID: 27572987 [TBL] [Abstract][Full Text] [Related]